Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Demographic and clinical characteristics of data collected from patients with screening samples by age and sex
| Screening samples | Comorbidities | Number of patients with susceptible results to different antibiotic classes, other than beta-lactamins | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Age | Sex | 0 | 1 | ≥2 | AG | FQ | SXT | Deceased | |
| <18 | Male | n= 2 6.25% | n=2 100% | - | - | - | - | - | - |
| Female | n= 1 3.12% | n=1 100% | - | - | - | - | - | - | |
| 19–60 | Male | n= 4 18.75% | - | n=1 16.66% | n=3 83.33% | n= 1 | n= 1 | - | n=4 100% |
| Female | n =2 6.25% | - | - | n=2 100% | n=1 | n=1 | - | n=0 | |
| >61 | Male | n= 20 62.5% | n=3 15% | n=5 25% | n=12 60% | - | - | - | n= 15 75% |
| Female | n= 3 9.37% | - | n=1 33.3% | n=2 66.66% | - | - | - | n= 2 66.66% | |
Demographic and clinical characteristics of data collected from patients with LRT pathological samples by age and sex
| Pathological samples | Comorbidities | number of patients with susceptible results to different antibiotic classes, other than beta-lactamins | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Age | Sex | 0 | 1 | ≥2 | AG | FQ | SXT | CT | Decesed | |
| <18 | Male | n= 1 3.33% | n=1 100% | - | - | - | - | - | - | |
| Female | n= 0 | - | - | - | - | - | - | - | - | |
| 19–60 | Male | n= 4 13.33% | - | n=4 100% | - | - | - | - | n=3 75% | n=3 75% |
| Female | n =0 | - | - | - | - | - | - | - | n=0 | |
| >61 | Male | n= 20 66.6% | n=2 10% | n=3 15% | n=15 75% | - | - | - | n=7 35% | n= 16 80% |
| Female | n= 5 16.66% | n=1 20% | n=1 20% | n=3 60% | - | - | - | n=4 75% | n= 3 60% | |